Skip to main content
logo
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
30.04
-1.47 (-4.67%)
At close: Mar 18, 2026, 4:00 PM EDT
30.12
+0.08 (0.27%)
After-hours: Mar 18, 2026, 4:02 PM EDT

TG Therapeutics Revenue

In the year 2025, TG Therapeutics had annual revenue of $616.29M with 87.32% growth. TG Therapeutics had revenue of $192.57M in the quarter ending December 31, 2025, with 78.00% growth.

Revenue (ttm)
$616.29M
Revenue Growth
+87.32%
P/S Ratio
7.86
Revenue / Employee
$1,544,579
Employees
399
Market Cap
4.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025616.29M287.28M87.32%
Dec 31, 2024329.00M95.34M40.80%
Dec 31, 2023233.66M230.88M8,290.02%
Dec 31, 20222.79M-3.90M-58.36%
Dec 31, 20216.69M6.54M4,300.66%
Dec 31, 2020152.00K--
Dec 31, 2019152.00K--
Dec 31, 2018152.00K--
Dec 31, 2017152.00K--
Dec 31, 2016152.00K-381.00-0.25%
Dec 31, 2015152.38K--
Dec 31, 2014152.38K--
Dec 31, 2013152.38K133.33K699.98%
Dec 31, 201219.05K--
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

TGTX News

More News